4Merkratz IR, Nitowsky HM, Macn JN, et al,An association between low maternal serum alpha- fetoprotein and fetal hromosomal abnormalities[J].AmJabstet Gynecol, 1984, 148:886-894. 被引量：1
5Salone R. Maternal Serums screenly for Down' s Syndrome on population basia[J].Acta Cyneology Stand, 1997,76:81 -87. 被引量：1
6Bearman JM, Goldie DJ. Second trimester screening for Down' s Syndrome:7year experlence[J].J Med screen ,2001,8:128-131. 被引量：1
4Wald NJ,Rodeck C,Hackshaw AK,et al.SURUSS in perspective[J].Semin Perinatol,2005,29:225-235. 被引量：1
5Palacio M,Jauniaux E,Kingdom J,et al.Perinatal outcome in pregnancies with a positive serum creening for Down's syndrome due to elevated levels of free beta-human chorionic gonadotropin[J].Ultrasound Obstet Gynecol,1999,13:58-62. 被引量：1
7Newberger DS. Down's syndrome: prenatal risk assessment and diagnosis. Am F amphysician, 2000, 62(4): 825-832. 被引量：1
8Beaman JM, Goldie DJ. Second trimester screening for Down's syndrome: 7 years experience. J Med Scre, 2001, 8(3): 128-131. 被引量：1
9Gekas J, van den Berg DG, Durand A, et al. Rapid testing versus karyotyping in Down's syndrome screening: c0st-effec- tiveness and detection of clinically significant chromosome ab- normalities. Eur J Hum Genet, 2011, 19( 1 ) : 3-9. 被引量：1
10Wald N J, Cuckle HS, Densem JW, et al. Maternal serum screening for Down's syndrome in early pregnancy. Br Med J, 1988, 297: 883-887. 被引量：1
